3M Company stock (US88579Y1010): spin-off, lawsuits and new dividend set the tone

3M Company is reshaping its portfolio with the Solventum health-care spin-off, fresh litigation settlements and a reset of its dividend policy. What this means for the industrial heavyweight and its US-focused investor base.

3M Company is in the midst of one of the largest transformations in its history. In early April 2024, the diversified industrial group completed the spin-off of its health-care business under the name Solventum and has since been operating as a leaner materials and industrial technologies company, according to 3M Investor Relations as of 04/01/2024. Alongside the portfolio shift, the company is dealing with large litigation settlements and has recently reset its dividend policy to reflect its smaller post spin-off cash flows, as highlighted by Reuters as of 04/30/2024.

As of: 19.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: 3M
• Sector/industry: Diversified industrials, materials and safety technology
• Headquarters/country: St. Paul, Minnesota, United States
• Core markets: United States, Europe, Asia-Pacific
• Key revenue drivers: Safety and industrial solutions, transportation and electronics, consumer products
• Home exchange/listing venue: New York Stock Exchange (ticker: MMM)
• Trading currency: US dollar (USD)

3M Company: core business model

3M Company is a US-based diversified manufacturer with a focus on engineered materials, adhesives, abrasives, filtration and safety products that are used across multiple industries worldwide. The group historically operated in four major segments and was known for combining applied chemistry and materials science to create products with recurring, consumable demand, according to 3M annual report as of 02/08/2024. Within the United States, the company holds a strong presence in industrial, automotive, healthcare and consumer markets, supplying both large corporate clients and retail channels.

Following the completion of the Solventum spin-off in April 2024, 3M’s business model has become more concentrated on industrial and safety solutions, consumer goods and transportation and electronics, while the stand-alone health-care operations are now separately listed. Management presented the spin-off as a strategic move to unlock value and allow each company to pursue more focused capital allocation and innovation strategies, according to 3M Investor Relations as of 04/01/2024. For remaining 3M shareholders, the core proposition rests on decades of patent-protected know-how and a broad portfolio of branded and technical products that can be distributed via global networks.

The company’s operating model relies heavily on its research and development capabilities, with a long tradition of allocating several percent of sales to R&D efforts. This approach has historically yielded a steady stream of new materials, tapes, filtration products and safety solutions that can be applied across different sectors, from electronics manufacturing to construction. At the same time, 3M uses large-scale manufacturing facilities, including many in the United States, to produce high volumes at competitive cost, creating economies of scale that are central to its margin profile, based on descriptions in the 3M annual report as of 02/08/2024.

3M also emphasizes close collaboration with its customers, particularly in industrial and automotive applications, where customized solutions can deepen client relationships and generate repeat orders. This customer-centric innovation model aims to integrate 3M products into manufacturing processes and end products, making them more difficult to replace and supporting long-term demand stability. The company’s wide product range and presence in multiple end-markets can mitigate cyclical swings in any single sector, though macroeconomic slowdowns and sector-specific headwinds still have a visible impact on revenue and earnings.

Main revenue and product drivers for 3M Company

Before the Solventum spin-off, 3M reported four segments: Safety and Industrial, Transportation and Electronics, Health Care and Consumer. The Safety and Industrial division generated a significant share of revenue with products such as personal protective equipment, industrial abrasives, tapes and adhesives that are used across manufacturing and construction. This segment has been particularly important in the US market, where industrial production and infrastructure activity drive demand, according to 3M annual report as of 02/08/2024. After the spin-off, this industrial exposure remains a core pillar of 3M’s revenue base.

The Transportation and Electronics segment contributes heavily through products used in automotive, aerospace and electronic devices, including films, connectors and insulation solutions. Demand in this area is linked to vehicle production, consumer electronics trends and investment in telecommunications infrastructure. In its first-quarter 2024 results, 3M mentioned ongoing cost controls and portfolio actions in transportation and electronics to enhance profitability, although detailed post spin-off segment figures were still being refined, as indicated by 3M Investor Relations as of 04/30/2024.

Consumer products are another important driver, particularly well-known brands such as Post-it notes, Scotch tapes and other home and office supplies that enjoy strong recognition in the United States and abroad. Although the consumer business typically has lower margins than highly specialized industrial solutions, it offers stable demand and wide distribution through retailers and e-commerce channels. In its 2023 annual report, 3M highlighted that consumer-facing products remained resilient, helped by brand loyalty and continuous improvements in product design and packaging, according to 3M annual report as of 02/08/2024.

Health care used to be a key revenue pillar prior to the Solventum separation, covering medical tapes, wound care, dental products and health information systems. With the spin-off, this revenue stream now sits outside 3M’s consolidated figures, which in turn affects the company’s overall sales scale and profitability metrics. Management acknowledged that the spin changed the financial profile of 3M and that dividend and capital allocation policies would be adjusted accordingly, as stated in the first-quarter 2024 earnings release as of 04/30/2024.

Across all remaining segments, 3M’s revenue is also influenced by regional exposure, with the United States typically representing a large share of sales. This creates direct relevance for US investors, as domestic economic growth, industrial production data and federal infrastructure spending can have a meaningful impact on order volumes. The company’s global footprint in Europe and Asia adds diversification, but also exposes it to currency fluctuations, geopolitical risks and varying regulatory frameworks.

Recent earnings, dividend reset and litigation settlements

In its first-quarter 2024 results, 3M reported adjusted earnings that reflected the deconsolidation of the health-care business and ongoing restructuring efforts, according to 3M Investor Relations as of 04/30/2024. The company pointed to productivity gains, cost reductions and portfolio actions as key drivers behind its profitability, while also acknowledging that certain end markets remained soft. Management reiterated its focus on strengthening the balance sheet, reducing debt and aligning the cost base with the smaller post spin-off enterprise.

One of the headline developments for income-focused investors was the reset of 3M’s dividend following the Solventum spin-off. In late April 2024, the company announced a quarterly dividend that represented a lower payout compared to its pre spin-off level, reflecting the reduced earnings and cash flow base of the stand-alone 3M, as noted by Reuters as of 04/30/2024. While the company continues to describe shareholder returns as a priority, the adjustment underlines a more conservative capital allocation stance in the wake of portfolio changes and legal settlements.

Litigation has been a defining theme for 3M in recent years, particularly regarding claims linked to so-called forever chemicals (PFAS) and earplugs sold to the US military. In 2023, 3M reached a proposed settlement related to PFAS contamination in US public water systems and a separate resolution addressing a large portion of the Combat Arms earplugs cases, according to 3M Investor Relations as of 06/22/2023 and 3M Investor Relations as of 08/29/2023. These agreements, while reducing legal uncertainty, also entail significant financial commitments that influence cash flows and debt levels over several years.

In its 2023 annual report, 3M outlined how these legal settlements and related reserves affect its financial statements and discussed ongoing risks that are still subject to court approval or further proceedings, according to 3M annual report as of 02/08/2024. For US investors, the settlement structures are particularly relevant because they can impact future earnings, capital allocation flexibility and overall risk perception of the stock. The combination of portfolio restructuring, dividend adjustments and litigation settlements shapes the current investment narrative around 3M.

Why 3M Company matters for US investors

3M Company is a long-standing component of the US industrial landscape and has historically been part of major indices that many American investors track. Its listing on the New York Stock Exchange under the ticker MMM and its broad institutional ownership base make it a closely watched name among market participants. Because 3M’s products flow into sectors such as manufacturing, construction, transportation and consumer spending, its performance can serve as a partial barometer for segments of the US real economy, as discussed in the 3M annual report as of 02/08/2024.

For income-oriented investors in the United States, 3M’s history of regular dividend payments has been a key attraction, even if the April 2024 reset marked a step change in the payout level. The company’s ongoing commitment to dividends, balanced against legal obligations and investment needs, will likely remain under scrutiny, particularly among retirees and long-term shareholders who rely on cash distributions. In addition, 3M’s scale and exposure to US industrial and consumer markets mean that changes in monetary policy, inflation trends and fiscal initiatives can feed through to its revenue and profit outlook.

The company’s prominent role in safety equipment and industrial productivity tools also connects it to themes such as workplace safety regulations, infrastructure upgrades and reshoring of manufacturing capacity to the United States. Policymakers’ focus on domestic production, supply chain resilience and environmental standards can influence demand for certain 3M products and shape the regulatory context in which the company operates. For US-based investors, monitoring these policy developments alongside 3M’s strategic responses provides additional context for understanding the stock’s longer-term risk and opportunity profile.

Conclusion

3M Company is navigating a complex period marked by the Solventum spin-off, significant litigation settlements and a recalibrated dividend policy that reflects its new financial profile. The core of the business now rests more squarely on industrial, safety, transportation and consumer products, supported by long-standing R&D capabilities and a broad customer base. For US investors, the stock remains closely tied to domestic economic conditions and regulatory developments, while cash flow dynamics, legal obligations and execution on restructuring plans are likely to shape sentiment. A balanced view therefore takes into account both the potential benefits of a more focused portfolio and the ongoing financial and operational challenges that 3M continues to manage.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.